Preview

Translational Medicine

Advanced search

A rare deleterious case of concomitant renal disease associated with IgG4-associated systemic disease

https://doi.org/10.18705/2311-4495-2024-11-4-364-370

Abstract

In IgG4-associated disease, several organs and tissues are often affected, especially kidney tissue, and is characterized by interstitial nephritis, obstructive nephropathy, and in rare cases glomerulopathy (including membra[1]nous nephropathy).

IgG4-associated disease was isolated as an independent nosological form in 2003, when patients with type 1 autoimmune pancreatitis were found signs of systemic damage (involvement of the biliary tract, salivary glands, retroperitoneal space), and in 2012 the first international nomenclature of the disease was proposed.

The clinical manifestations of IgG4-associated disease are nonspecific and diverse, which determines the difficulties of differential diagnosis, including infections and tumors, and increases the period from the onset of the disease to diagnosis to an average of 2 years. IgG4-associated disease is more likely to develop in middle age and old age. The prevalence of the disease is higher among men than among women. Thus, autoimmune pancreatitis type 1, retroperitoneal fibrosis and tubulointerstitial nephritis are more common in men, and sialoadenitis, dacryoadenitis and thyroiditis are more common in women.

In this article, we present a clinical case of IgG4-associated systemic disease with a combined lesion of the tubulo-interstitial and glomerular compartments of kidney tissue with nephrotic syndrome as the only initial manifestation. The combination of IgG4-tubulo-interstitial nephritis with membranous nephropathy is an ex[1]tremely rare pathology. Nephrobiopsy was crucial in the diagnosis of this condition, which allowed the patient to be prescribed proper and timely treatment.

About the Authors

Yu. V. Lavrishcheva
Almazov National Medical Research Centre
Russian Federation

Yulia V. Lavrischeva, PhD, Associate Professor of the Department of Faculty Therapy with the clinic

Akkuratova str., 2, Saint Petersburg, 197341


Competing Interests:

The authors declare no conflict of interest



A. A. Jakovenko
Academician I. P. Pavlov First Saint Petersburg State Medical University
Russian Federation

Alexandr A. Jakovenko, PhD, Associate Professor of the Department of Nephrology and Dialysis

Saint Petersburg


Competing Interests:

The authors declare no conflict of interest



I. V. Potapov
Almazov National Medical Research Centre
Russian Federation

Ilya V. Potapov, sixth year student, Institute of Medical Education

Saint Petersburg


Competing Interests:

The authors declare no conflict of interest



References

1. Koneczny I. A New Classification System for IgG4 Autoantibodies. Front Immunol. 2018; 9: 97. DOI: 10.3389/fimmu.2018.00097.

2. Huijbers MG, Querol LA, Niks EH, et al. The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol. 2015; 22(8): 1151–1161. DOI: 10.1111/ene.12758.

3. Zykova A, Novikov P, Brovko M, et al. IgG4-related disease: the state of art. Klinicheskaya farmakologiya I terapiya = Clin Pharmacol Ther 2020;29(3):4–13. In Russian

4. Zakharova EV, Vorobjova OA. Immunoglobulin g4-related disease, presented with retroperitoneal fibrosis and monoclonal gammopathy: case report and mini review. Urol Nephrol Open Access J. 2015;2(5):168‒173. DOI: 10.15406/unoaj.2015.02.00058.

5. Voloshinova EV, Vorobyeva OA, Tsaturova KN. A clinical case of IgG4-releated disease. Nephrology and Dialysis. 2018;20(1):92‒99. In Russian

6. Huijbers MG, Plomp JJ, van der Maarel SM, et al. IgG4-mediated autoimmune diseases: a niche of antibodymediated disorders. Ann N Y Acad Sci. 2018;1413(1): 92‒103. DOI: 10.1111/nyas.13561.

7. Vasilenko VV, Vinogradov DL, Burlakova AS. IgG4-related disease: condition of the problem. The Russian Archives of Internal Medicine. 2017;7(2):95‒106. In Russian

8. Takahashi N, Ghazale AH, Smyrk TC, et al. Possible association between IgG4-Associated systemic disease with or without autoimmune pancreatitis and nonHodgkin lymphoma. Pancreas. 2009;38(5):523‒526. DOI: 10.1097/MPA.0b013e31819d73ca.

9. Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78(10):1016‒1023. DOI: 10.1038/ki.2010.271.

10. Syedyshev SH, Vasiliev VI, Kovrigina AM. Diagnosis of a new nosological group: IgG4-associated systemic disease. Nuchno-prakticheskaya revmatologiya. The collection of materials II Congress of Rheumatology Russia, April 26‒29, 2011. Yaroslavl. P. 70. In Russian

11. Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015;67(9):2466–2475. DOI: 10.1002/art.39205.

12. Cheuk W, Lee KC, Chong LY, et al. IgG4-related Sclerosing disease: a potential new etiology of cutaneous pseudolymphoma. Am J Surg Pathol. 2009;33(11):1713–1719. DOI: 10.1097/PAS.0b013e3181b201de.


Review

For citations:


Lavrishcheva Yu.V., Jakovenko A.A., Potapov I.V. A rare deleterious case of concomitant renal disease associated with IgG4-associated systemic disease. Translational Medicine. 2024;11(4):364-370. (In Russ.) https://doi.org/10.18705/2311-4495-2024-11-4-364-370

Views: 212


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2311-4495 (Print)
ISSN 2410-5155 (Online)